Please login to the form below
Data protection
This page shows the latest Data protection news and features for those working in and with pharma, biotech and healthcare.
Pfizer highlights need for fourth dose of COVID-19 vaccine to FDA
Commenting on the immune protection provided by vaccines, Bourla said: “The data shows the immune protection against Omicron is very good after three doses, but when it comes against hospitalisation or ... However, trial data published in February from
Latest news
-
Moderna begins phase 2 trial of Omicron-specific booster
We will continue to share data with public health authorities to help them make evidence-based decisions on the best booster strategies against SARS-CoV-2.". ... Data showing protection levels against Omicron six months after being given a booster shot
-
Pfizer and BioNTech start clinical trial for Omicron-based COVID-19 vaccine
While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognise the need to be ... Yet, emerging data indicate vaccine-induced protection
-
US health leaders greenlight COVID-19 booster shots for “all Americans”
However, the available data makes it “very clear that protection against SARS-CoV-2 infection begins to decrease over time following the initial doses of vaccination”, they said, adding that, with ... the dominance of the delta variant, “we are
-
Pfizer/BioNTech submit data for COVID-19 booster shots
The warning was given by Francis Collins, director of the National Institutes for Health, who said data from Israel suggesting that vaccine protection was waning among older people should make heath ... The FDA has already given approval for a booster
-
Health leaders welcome EDPB’s opinion on adequacy of UK’s data protection standards
Health leaders have welcomed the opinion adopted by the European Data Protection Board (EDPB) regarding the adequate protection of personal data in the UK. ... Despite these challenges, the draft opinion “gives the green light to UK data protection
More from news
Approximately 1 fully matching, plus 65 partially matching documents found.
Latest Intelligence
-
Digitising healthcare
The challenge lies in a lack of standards and data interoperability between IoT devices, as it results in inconsistencies in device implementation. ... Patient data protection. Data breaches and data mistrust are key terms in the media, as headlines
-
Why digital is the solution to the healthcare crisis
From a consumer perspective, there is a hesitance to share private medical data digitally. ... Doing so will make healthcare provision more efficient and effective. The technology already exists, as does the data protection; there are different levels of
-
Integrating electronic health records into clinical trials
research. These opportunities could improve data quality, streamline processes and lead to better protocols. ... This really transforms the whole way that we do medicines research and development,” Brendan Barnes, director of IP and data protection at
-
Mastering data protection in the pharma industry
data within pharmacovigilance reporting requirements while complying with the EU data protection rules. ... in consultation with the UK ICO, also published guidance on UK data protection in post-marketing pharmacovigilance.
-
Pharmaceutical social media after Cambridge Analytica
But a Facebook loophole also allowed GSR to access the users’ friends’ data. ... EU General Data Protection Regulation (GPDR) has reset the rules on data processing.
More from intelligence
Approximately 1 fully matching, plus 23 partially matching documents found.
Latest appointments
-
UK names guardian for national health data
data. According to the DH, Dame Fiona will be the “patients' champion on security of personal medical information” to guarantee that personal data is protected. ... Her experience in data protection includes heading the Independent Information
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
11, 12. With research underway and data accumulating, this was another point where modern technologies were able to benefit the vaccine development process. ... 15. However, the uses of digital will depend on variations in data protection laws and the
-
Remote Patient Monitoring
The regulatory and technical environment they will operate in and protection of patient data is paramount. ... huge. With a patient-centric, digital-first approach, the wider health economy will gain from a huge influx of data.
-
Digital Therapeutics Landscape in Europe
1. to find the needed support for their health. While these developments could create new risks for privacy and data protection, they also represent an unprecedented opportunity to integrate industry
-
Are you capitalising on your pharma exhibition presence?
Deploy lead capture technology/software. Provide the means for people to share their data quickly and easily. ... So, you must make sure that all the data you capture is done in line with current data protection legislation.
-
How to create an ethical pharma exhibition stand
Data can be used to enhance your business intelligence functions, leading to more complete customer profiles, better insights and analysis, and more detailed sales reporting. ... So it makes sense that you’d want to use your exhibition experience to
More from PMHub
Approximately 2 fully matching, plus 17 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
